Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis

Study summary

This is a study that will evaluate the utility of a scatter reduction technique in reducing dose and increasing the sensitivity of stationary digital chest tomosynthesis (s-DCT) in the detection of lung lesions.

Ask AI to explain this study

Start here

Key things to know

Main goalDiagnostic

This describes the study’s primary purpose.

What is being studiedScatter corrected s-DCT

The study team can explain what participation involves.

Who it may be forPulmonary Nodule, Solitary · Pulmonary Nodule, Multiple

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 8, 2022 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?UNC Lineberger Comprehensive Cancer Center

Study sponsor

Study overview

What this study is about

Purpose: Diagnostic
Study type: Interventional
Phase: Not applicable
Sponsor: UNC Lineberger Comprehensive Cancer Center
Interventions being studied: Device: Scatter corrected s-DCT

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Patients with known lung lesion(s)
Patients having undergone a chest CT
Patients 18 years of age and older
Patients able to provide informed consent

Reasons someone may not be able to joinExclusion criteria

Patients who may not fit on a 35 x 35 detector (BMI \> 35)
Planned procedures or therapies during study (in between SOC scans and study scan on s-DCT) (biopsy or removal of lung lesion)
Any woman who is pregnant, has reason to believe she is pregnant, or is lactating

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

University of North Carolina at Chapel HillChapel Hill, North Carolina

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 8, 2022. Always confirm current availability with the study team.

View original record ↗